Pharmaceutical giant Moderna said it would start testing its COVID-19 vaccine on children ages 12 through 17.
The study, listed on Clinicaltrials.gov, is ”designed to primarily evaluate the safety and reactogenicity of a single dose level of mRNA-1273 vaccine administered in 2 doses 28 days apart to an adolescent population” and will include 3,000 children.
Participants will receive one intramuscular injection on Day 1 and Day 29. Half of the participants will get placebo shots of saltwater.
Moderna’s vaccine has not been studied in children or pregnant women but its coronavirus vaccine has shown to be highly effective in adults. The drugmaker on Monday said complete data from a large study show its vaccine to be 94.1 percent effective.
Read more at NEWSMAX.
{Matzav.com}
